TY - JOUR T1 - A cohort of patients with COVID-19 in a major teaching hospital in Europe JF - medRxiv DO - 10.1101/2020.04.29.20080853 SP - 2020.04.29.20080853 AU - Alberto M. Borobia AU - Antonio J. Carcas AU - Francisco Arnalich AU - Rodolfo Álvarez-Sala AU - Jaime Montserrat AU - Manuel Quintana AU - Juan Carlos Figueira AU - Rosario M. Torres Santos-Olmo AU - Julio García-Rodríguez AU - Alberto Martín-Vega AU - Antonio Buño AU - Elena Ramírez AU - Gonzalo Martínez-Alés AU - Nicolás García-Arenzana Les AU - M. Concepción Núñez AU - Milagros Martí-de-Gracia AU - Francisco Moreno Ramos AU - Francisco Reinoso-Barbero AU - Alejandro Martin-Quiros AU - Angélica Rivera Núñez AU - Jesús Mingorance AU - Carlos J Carpio Segura AU - Daniel Prieto Arribas AU - Esther Rey Cuevas AU - Concepción Prados Sánchez AU - Juan J. Rios AU - Miguel A. Hernán AU - Jesús Frías AU - José R Arribas AU - for the COVID@HULP Working Group Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/06/2020.04.29.20080853.abstract N2 - BACKGROUND Since the confirmation of the first patient infected with SARS-CoV-2 in Spain in January 2020, the epidemic has grown rapidly, with the greatest impact on the Madrid region. This article describes the first 2226 consecutive adult patients with COVID-19 admitted to the La Paz University Hospital in Madrid.METHODS Our cohort included all consecutively admitted patients who were hospitalized and who had a final outcome (death or discharge) in a 1286-bed hospital of Madrid (Spain) from February 25th (first case admitted) to April 19th, 2020. Data was entered manually into an electronic case report form, which was monitored prior to the analysis.RESULTS We consecutively included 2226 adult patients admitted to the hospital who either died (460) or were discharged (1766). The patients’ median age was 61 years; 51.8% were women. The most common comorbidity was arterial hypertension (41.3%). The most common symptom on admission were fever (71.2%). The median time from disease onset to hospital admission was 6 days. Overall mortality was 20.7% and was higher in men (26.6% vs 15.1%). Seventy-five patients with a final outcome were transferred to the ICU (3.4%). Most patients admitted to the ICU were men, and the median age was 64 years. Baseline laboratory values on admission were consistent with an impaired immune-inflammatory profile.CONCLUSIONS We provide a description of the first large cohort of hospitalized patients with COVID-19 in Europe. Advanced age, male gender, the presence of comorbidities and abnormal laboratory values were more common among the patients with fatal outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNA ER -